Piper Sandler sets USD 160.00 target for iRhythm Technologies stock

Published on 10/17/2026 at 22:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 224.17 million in the second quarter. iRhythm Technologies stock was last at USD 108.66 on October 16, 2026, down 0.63 percent on Nasdaq.

Analyst target and November date

Piper Sandler set a USD 160.00 target for iRhythm Technologies on October 16, 2026.
Second-quarter revenue rose 20.1 percent to USD 224.17 million.
iRhythm Technologies stock was last at USD 108.66 on October 16, 2026, down 0.63 percent on Nasdaq.
Third-quarter results are scheduled for November 5, 2026, while market capitalization stood at USD 3.6 billion.

IRMD, US4500561067, Illustration mit AI erstellt.

iRhythm Technologies (ISIN US4500561067) received a new USD 160.00 price target from Piper Sandler on October 16, 2026, putting the target 47.25 percent above the Nasdaq price of USD 108.66. The stock was last at USD 108.66 on Nasdaq on October 16, 2026, at 4:00 p.m. ET, down 0.63 percent from its prior close of USD 109.35.

Second-quarter revenue reached USD 224.17 million

iRhythm's operating progress gives the analyst view a measurable foundation. According to iRhythm Technologies, revenue in the second quarter of 2026 rose 20.1 percent year over year to USD 224.2 million. Gross margin increased to 72.8 percent from 71.2 percent in the second quarter of 2025, while GAAP net loss narrowed to USD 0.4 million from USD 14.2 million.

The release also reported adjusted net income of USD 19.3 million, or USD 0.58 adjusted earnings per share, in the second quarter of 2026. The comparison includes litigation settlements and cybersecurity-related costs in the adjusted reconciliation, so the adjusted result should not be read as a GAAP profit.

Range and volume keep the stock volatile

IRTC's USD 100.70 to USD 212.00 52-week range puts the October 16 price 7.91 percent above the low and 48.75 percent below the high. Trading volume was 398,615 shares against an average of 559,573 shares, a 28.77 percent shortfall to the average. The range therefore remains a more useful placement measure than the daily move alone.

Valuation points to November 5

The company had a market capitalization of USD 3.6 billion and a trailing price-to-earnings ratio of minus 252.70 as of October 16, 2026. A negative multiple reflects the company's recent earnings profile rather than a conventional earnings valuation. Yahoo Finance reported on October 15, 2026 that iRhythm will release third-quarter 2026 results after the close on November 5, 2026, followed by a conference call at 4:30 p.m. ET.

The November date gives the target and the second-quarter operating figures a clear test. Revenue guidance for fiscal year 2026 stands at USD 880 million to USD 890 million, with adjusted EBITDA margin guidance of 13.0 percent to 14.0 percent, according to the company release.

Nasdaq quote sets the price frame

For investors, the key contrast is the distance between the USD 160.00 Piper Sandler target and the USD 108.66 Nasdaq price, alongside a 52-week high that is nearly twice the current level. The next results date may provide the next formal checkpoint for that valuation gap.